Literature DB >> 10221744

Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication.

B Franz1, D J Buysse, C R Cherry, N S Gray, V J Grochocinski, E Frank, D J Kupfer.   

Abstract

This study was undertaken in order to advance our understanding of the distal growth hormone axis in depression. Insulin-like growth factor 1 (IGF-1) and growth hormone binding protein (GHBP) were measured in a group of 19 depressed women and a group of 16 healthy women. Using a generalized linear model, IGF-1 levels were negatively correlated with age (p = 0.0001), influenced by menstrual phase (p = 0.016), and significantly increased in the depressed group (p = 0.02). Using the same type of analysis, GHBP was significantly related to menstrual phase (p = 0.0001) and body mass index (p = 0.0001), but was not significantly different in patients and controls. IGF-1 and GHBP were positively correlated among healthy subjects (r = 0.46, p = 0.08), but not among depressed patients (r = -0.16, p = 0.51), although these correlation coefficients were not statistically significantly different from each other. These findings confirm the importance of several physiological factors in the regulation of IGF-1 and GHBP, and suggest that depression further influences this regulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221744     DOI: 10.1016/s0022-3956(98)00066-1

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  10 in total

Review 1.  Endocrine disturbances in depression.

Authors:  M A Tichomirowa; M E Keck; H J Schneider; M Paez-Pereda; U Renner; F Holsboer; G K Stalla
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 2.  Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.

Authors:  Ajaykumar N Sharma; Bruno Fernando Borges da Costa e Silva; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  J Affect Disord       Date:  2016-03-02       Impact factor: 4.839

Review 3.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

4.  The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder.

Authors:  Meysam Amidfar; Gislaine Zilli Réus; Airam Barbosa de Moura; João Quevedo; Yong-Ku Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy.

Authors:  Alexandra S Troyan; Oleg A Levada
Journal:  Front Psychiatry       Date:  2020-08-13       Impact factor: 4.157

6.  Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study.

Authors:  Yan Wang; Ming Huang; Jian-tong Jiao; Yan-li Wu; Tao-hui Ouyang; Ju Huang; Sha-sha Liu; Chun-lin Li
Journal:  Med Oncol       Date:  2014-03-26       Impact factor: 3.064

7.  Insulin-like growth factor 1 and risk of depression in older people: the English Longitudinal Study of Ageing.

Authors:  S Chigogora; P Zaninotto; M Kivimaki; A Steptoe; G D Batty
Journal:  Transl Psychiatry       Date:  2016-09-20       Impact factor: 6.222

8.  MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c.

Authors:  A Gururajan; M E Naughton; K A Scott; R M O'Connor; G Moloney; G Clarke; J Dowling; A Walsh; F Ismail; G Shorten; L Scott; D M McLoughlin; J F Cryan; T G Dinan
Journal:  Transl Psychiatry       Date:  2016-08-02       Impact factor: 6.222

Review 9.  Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder.

Authors:  Oleg A Levada; Alexandra S Troyan
Journal:  Ann Gen Psychiatry       Date:  2017-10-26       Impact factor: 3.455

Review 10.  Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA.

Authors:  Kun-Yu Tu; Ming-Kung Wu; Yen-Wen Chen; Pao-Yen Lin; Hung-Yu Wang; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.